KRAS Mutations Impact Clinical Outcome in Metastatic Non-Small Cell Lung Cancer

SIMPLE SUMMARY: In this retrospective study including 580 patients with metastatic (Stage IV) non-small cell lung cancer, we investigated whether KRAS mutational status had any impact on clinical outcome. First, we analyzed overall survival of patients grouped based on absence (KRAS(WT)) or presence...

Descripción completa

Detalles Bibliográficos
Autores principales: Eklund, Ella A., Wiel, Clotilde, Fagman, Henrik, Akyürek, Levent M., Raghavan, Sukanya, Nyman, Jan, Hallqvist, Andreas, Sayin, Volkan I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103674/
https://www.ncbi.nlm.nih.gov/pubmed/35565194
http://dx.doi.org/10.3390/cancers14092063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103674/
https://www.ncbi.nlm.nih.gov/pubmed/35565194
http://dx.doi.org/10.3390/cancers14092063

Ejemplares similares